ArticleLiver cancer2026

Sequential ICI plus Anti-VEGF/TKI with On-Demand TACE beyond RECIST Progression Improves Pathological Response, Resectability, and Survival in Unresectable HCC.

Masatoshi KudoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.